Carnegie Investment Counsel’s Elevance Health ELV Stock Holding History

Carnegie Investment Counsel’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,116	Closed	-$605K	–	470
2024 Q2	$605K	Sell	1,116 -231	-17%	-$122K	0.02%	318
2024 Q1	$698K	Sell	1,347 -54	-4%	-$26.9K	0.02%	323
2023 Q4	$660K	Buy	+1,401	New	+$648K	0.02%	327
2023 Q2	–	Sell	-436	Closed	-$200K	–	501
2023 Q1	$200K	Sell	436 -1	-0.2%	-$476	0.01%	494
2022 Q4	$224K	Sell	437 -5	-1%	-$2.54K	0.01%	469
2022 Q3	$201K	Sell	442 -44	-9%	-$21.1K	0.01%	457
2022 Q2	$235K	Buy	486 +66	+16%	+$32.7K	0.01%	435
2022 Q1	$206K	Buy	+420	New	+$192K	0.01%	472

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Carnegie Investment Counsel's ELV Position: Q3 2024 in Review

Carnegie Investment Counsel sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 1,116 shares — an estimated $605K sold.

Carnegie Investment Counsel first reported a position in ELV in Q1 2022 and held it in 8 quarters. The position peaked at $698K in Q1 2024. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

Carnegie Investment Counsel reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
Carnegie Investment Counsel sold 1,116 Elevance Health shares in Q3 2024, an estimated $605K.
Carnegie Investment Counsel first reported a position in Elevance Health in Q1 2022 and held it in 8 quarters.
Carnegie Investment Counsel's Elevance Health position peaked at $698K in Q1 2024.
1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Carnegie Investment Counsel's 13F filing for Q3 2024, filed 10 Oct 2024.